Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) EBIT (2020 - 2025)

Historic EBIT for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $19.0 million.

  • Cellebrite DI's EBIT fell 233.99% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.4 million, marking a year-over-year increase of 929.9%. This contributed to the annual value of $56.9 million for FY2024, which is 7121.28% up from last year.
  • As of Q3 2025, Cellebrite DI's EBIT stood at $19.0 million, which was down 233.99% from $14.4 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's EBIT registered a high of $19.4 million during Q3 2024, and its lowest value of -$5.6 million during Q2 2022.
  • For the 5-year period, Cellebrite DI's EBIT averaged around $8.5 million, with its median value being $9.2 million (2024).
  • Its EBIT has fluctuated over the past 5 years, first crashed by 16810.61% in 2022, then skyrocketed by 669926.47% in 2024.
  • Cellebrite DI's EBIT (Quarter) stood at $4.3 million in 2021, then soared by 124.66% to $9.7 million in 2022, then soared by 55.04% to $15.0 million in 2023, then increased by 4.85% to $15.7 million in 2024, then rose by 20.75% to $19.0 million in 2025.
  • Its last three reported values are $19.0 million in Q3 2025, $14.4 million for Q2 2025, and $12.3 million during Q1 2025.